EP2 Receptor Signaling Regulates Microglia Death
- 1 July 2015
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 88 (1) , 161-170
Abstract
The timely resolution of inflammation prevents continued tissue damage after an initial insult. In the brain, the death of activated microglia by apoptosis has been proposed as one mechanism to resolve brain inflammation. How microglial death is regulated after activation is still unclear. We reported that exposure to lipopolysaccharide (LPS) and interleukin (IL)-13 together initially activates and then kills rat microglia in culture by a mechanism dependent on cyclooxygenase-2 (COX-2). We show here that activation of the E prostanoid receptor 2 (EP2, PTGER2) for prostaglandin E2 mediates microglial death induced by LPS/IL-13, and that EP2 activation by agonist alone kills microglia. Both EP2 antagonists and reactive oxygen scavengers block microglial death induced by either LPS/IL-13 or EP2 activation. By contrast, the homeostatic induction of heme oxygenase 1 (Hmox1) by LPS/IL-13 or EP2 activation protects microglia. Both the Hmox1 inducer cobalt protoporphyrin and a compound that releases the Hmox1 product carbon monoxide (CO) attenuated microglial death produced by LPS/IL-13. Whereas CO reduced COX-2 protein expression, EP2 activation increased Hmox1 and COX-2 expression at both the mRNA and protein level. Interestingly, caspase-1 inhibition prevented microglial death induced by either LPS/IL-13 or low (but not high) concentrations of butaprost, suggestive of a predominantly pyroptotic mode of death. Butaprost also caused the expression of activated caspase-3 in microglia, pointing to apoptosis. These results indicate that EP2 activation, which initially promotes microglial activation, later causes delayed death of activated microglia, potentially contributing to the resolution phase of neuroinflammation.Keywords
This publication has 49 references indexed in Scilit:
- Interleukin-4- and Interleukin-13-Mediated Alternatively Activated Macrophages: Roles in Homeostasis and DiseaseAnnual Review of Immunology, 2013
- P2X7 Receptor Activation Induces Reactive Oxygen Species Formation and Cell Death in Murine EOC13 MicrogliaMediators of Inflammation, 2013
- Heme induces programmed necrosis on macrophages through autocrine TNF and ROS productionBlood, 2012
- Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2Proceedings of the National Academy of Sciences, 2012
- The Prostaglandin E2 E-Prostanoid 4 Receptor Exerts Anti-Inflammatory Effects in Brain Innate ImmunityThe Journal of Immunology, 2010
- Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptorProceedings of the National Academy of Sciences, 2010
- The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosisAnnals of Neurology, 2008
- Caspase-1 Regulates Escherichia coli Sepsis and Splenic B Cell Apoptosis Independently of Interleukin-1β and Interleukin-18American Journal of Respiratory and Critical Care Medicine, 2006
- Microglia expressing interleukin‐13 undergo cell death and contribute to neuronal survival in vivoGlia, 2004
- Interleukin‐13 and ‐4 induce death of activated microgliaGlia, 2002